{"id":415560,"date":"2021-01-15T00:24:45","date_gmt":"2021-01-15T05:24:45","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=415560"},"modified":"2021-01-15T00:24:45","modified_gmt":"2021-01-15T05:24:45","slug":"orthocell-receives-us-market-clearance","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/","title":{"rendered":"Orthocell Receives US Market Clearance"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Orthocell Receives US Market Clearance<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAustralian-based regenerative medicine company, Orthocell Ltd, has received US 510k clearance to market and supply its collagen medical device for dental bone and tissue regeneration procedures\n<\/li>\n<li>\nStrong partnering potential, with US, EU and AU market approval now in place\n<\/li>\n<li>\nStriate<sup>+TM <\/sup>established as the new global brand for dental bone and tissue regeneration product\n<\/li>\n<\/ul>\n<p>PERTH, Australia&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAustralian-based regenerative medicine company, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.orthocell.com.au%2F&amp;esheet=52362367&amp;newsitemid=20210114006090&amp;lan=en-US&amp;anchor=Orthocell+Ltd&amp;index=1&amp;md5=abb82f4ddc561fbe83bbf2c27525b503\">Orthocell Ltd<\/a> (ASX:OCC, \u201cOrthocell\u201d or the \u201cCompany\u201d), has achieved US 510k clearance to market and supply its collagen medical device Striate<sup>+TM<\/sup> in the US dental bone and tissue regeneration market.\n<\/p>\n<p><b>Orthocell Managing Director, Paul Anderson, said:<\/b><i \/>\u201cUS approval is a significant inflection point for our Company, and we are now primed to partner and distribute this product. I look forward to working with our leading dental surgeons to introduce the new global brand, Striate<sup>+TM<\/sup> \u2013 previously branded as CelGro\u00ae dental \u2013 to make a meaningful impact in the US market.\u201d\n<\/p>\n<p>\nThe US 510(k) clearance now allows Orthocell to supply Striate<sup>+TM<\/sup> in the US dental bone and tissue regeneration market, estimated at US$500 million per annum<sup>1<\/sup>. The Company will now pursue negotiations with multi-national dental companies for US marketing and distribution rights, with Orthocell to retain manufacturing of the finished product.\n<\/p>\n<p>\nStriate<sup>+TM<\/sup> has been approved for use in dental bone and tissue regeneration procedures including, but not limited to, dental bone defect repair, augmentation around dental implants in immediate and delayed extraction sockets and guided tissue regeneration procedures in intrabony periodontal defects.\n<\/p>\n<p><b>Leading US dental surgeon, Dr Pamela Ray, said: \u201c<\/b>Striate<sup>+TM <\/sup>has exceptional handling qualities &#8211; when manipulating, it remains dimensionally stable and unrolls easily back to the original size. It has great tensile strength and does not deform when hydrated. I am excited by this innovative product and its potential. I believe it will assist with improving patient outcomes and I look forward to working with the team at Orthocell as it enters the US market.\u201d\n<\/p>\n<p>\nThe 510(k) clearance follows the Company\u2019s application submitted to the FDA in May 2020. The FDA determined that, for the indications above, Orthocell&#8217;s Striate+ is substantially equivalent to a predicate device and can therefore market Striate+ in the US. Striate+ has, based on surgeon feedback, distinct advantages over other similar products and may assist surgeons to deliver improved patient outcomes through superior handling characteristics, tissue integration qualities and improved bone healing.\n<\/p>\n<p>\nWith US, EU and Australian market approval achieved and key opinion leaders (KOLs) actively engaging with the program, Orthocell is well positioned to secure a distribution partner and establish Striate+TM as the best-in-class dental resorbable collagen membrane.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210114006090\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210114006090\/en\/<\/a><\/span><\/p>\n<p><b>Media enquiries:<\/b><\/p>\n<p><b>H^CK Director, Haley Chartres<br \/>\n<\/b><br \/>P: +61 423 139 163<br \/>\n<br \/>E: <a rel=\"nofollow\" href=\"mailto:haley@hck.digital\">haley@hck.digital<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Australia\/Oceania Australia<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Science Other Science Biotechnology Research General Health Health Medical Devices Dental<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210114006090\/en\/852585\/3\/Orthocell_Logo_Primary_RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell Receives US Market Clearance Australian-based regenerative medicine company, Orthocell Ltd, has received US 510k clearance to market and supply its collagen medical device for dental bone and tissue regeneration procedures Strong partnering potential, with US, EU and AU market approval now in place Striate+TM established as the new global brand for dental bone and tissue regeneration product PERTH, Australia&#8211;(BUSINESS WIRE)&#8211; Australian-based regenerative medicine company, Orthocell Ltd (ASX:OCC, \u201cOrthocell\u201d or the \u201cCompany\u201d), has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market. Orthocell Managing Director, Paul Anderson, said:\u201cUS approval is a significant inflection point for our Company, and we are now primed to partner and distribute this &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Orthocell Receives US Market Clearance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-415560","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Orthocell Receives US Market Clearance - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Orthocell Receives US Market Clearance - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Orthocell Receives US Market Clearance Australian-based regenerative medicine company, Orthocell Ltd, has received US 510k clearance to market and supply its collagen medical device for dental bone and tissue regeneration procedures Strong partnering potential, with US, EU and AU market approval now in place Striate+TM established as the new global brand for dental bone and tissue regeneration product PERTH, Australia&#8211;(BUSINESS WIRE)&#8211; Australian-based regenerative medicine company, Orthocell Ltd (ASX:OCC, \u201cOrthocell\u201d or the \u201cCompany\u201d), has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market. Orthocell Managing Director, Paul Anderson, said:\u201cUS approval is a significant inflection point for our Company, and we are now primed to partner and distribute this &hellip; Continue reading &quot;Orthocell Receives US Market Clearance&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-15T05:24:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Orthocell Receives US Market Clearance\",\"datePublished\":\"2021-01-15T05:24:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/\"},\"wordCount\":486,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/\",\"name\":\"Orthocell Receives US Market Clearance - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-01-15T05:24:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orthocell-receives-us-market-clearance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Orthocell Receives US Market Clearance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Orthocell Receives US Market Clearance - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/","og_locale":"en_US","og_type":"article","og_title":"Orthocell Receives US Market Clearance - Market Newsdesk","og_description":"Orthocell Receives US Market Clearance Australian-based regenerative medicine company, Orthocell Ltd, has received US 510k clearance to market and supply its collagen medical device for dental bone and tissue regeneration procedures Strong partnering potential, with US, EU and AU market approval now in place Striate+TM established as the new global brand for dental bone and tissue regeneration product PERTH, Australia&#8211;(BUSINESS WIRE)&#8211; Australian-based regenerative medicine company, Orthocell Ltd (ASX:OCC, \u201cOrthocell\u201d or the \u201cCompany\u201d), has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market. Orthocell Managing Director, Paul Anderson, said:\u201cUS approval is a significant inflection point for our Company, and we are now primed to partner and distribute this &hellip; Continue reading \"Orthocell Receives US Market Clearance\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-15T05:24:45+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Orthocell Receives US Market Clearance","datePublished":"2021-01-15T05:24:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/"},"wordCount":486,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/","name":"Orthocell Receives US Market Clearance - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-01-15T05:24:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210114006090r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orthocell-receives-us-market-clearance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Orthocell Receives US Market Clearance"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/415560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=415560"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/415560\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=415560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=415560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=415560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}